GLOW Peptide Blend in Australia

Pre-blended GHK-Cu, BPC-157 and TB-500 for skin and repair research. GLOW is a three-peptide blend built around GHK-Cu, with BPC-157 and TB-500 added for their repair and cell-migration mechanisms. The combination is designed for skin and connective-tissue research where collagen signalling, inflammation control and cell migration all matter at once.

Dermal remodelling: collagen deposition and elasticity endpoints. Repair signalling: combined growth-factor and cytoskeletal pathways. Single-solution handling: fixed ratio across three peptides. No trial has tested the blend as a single product. Each component has its own literature, summarised on the individual compound pages. Researchers should treat GLOW as a fixed-ratio convenience rather than a validated combination.

Not tested as a single product. GHK-Cu's topical skin results, BPC-157's repair models and TB-500's migration data are the evidence base, each on its own page.

No combined data. The topical GHK-Cu record is good; BPC-157 and TB-500 have no human safety studies.

Published GLOW Peptide Blend studies specify their own amounts and routes, and those vary by model and endpoint. Peptide Aus products are supplied for in-vitro laboratory research, so we do not provide dosing, cycle or usage guidance for people. For laboratory preparation, the reconstitution calculator converts vial size and water volume into concentration and syringe units.

KLOW is GLOW plus KPV, the anti-inflammatory tripeptide, in a larger 80mg vial. Choose KLOW when inflammation control is part of the question.

GHK-Cu alone isolates the copper-peptide effect; GLOW adds two repair peptides.

GHK-Cu, BPC-157 and TB-500. The 50mg vial holds 50mg total; the 70mg vial holds 70mg at the same ratio. Exact composition is on each batch certificate.

KLOW is GLOW plus KPV, the anti-inflammatory tripeptide. Choose KLOW when inflammation control is part of the research question.

With bacteriostatic water added slowly down the inside wall of the vial, then swirled gently. Each vial size lists its suggested volume, and the calculator converts volume to concentration.

Lyophilised: −20 °C, sealed, away from light and moisture. Reconstituted: 2–8 °C, used within 8–12 weeks, never frozen.

GLOW Peptide Blend is not registered by the Therapeutic Goods Administration (TGA) as a medicine in Australia and is not approved for human or veterinary use. Peptide Aus supplies it as a research reagent for in-vitro laboratory work only. Supply of any substance for human use in Australia is governed by the Poisons Standard and the Therapeutic Goods Act, and the buyer is responsible for using the material lawfully. If you are looking for a treatment, speak to a doctor.

Directly from Peptide Aus, from Australian stock, in 2 vial sizes from $168.99 (50mg) to $199.99 (70mg). Prices are AUD and GST inclusive. Paid orders before 2pm AEST/AEDT dispatch the same business day, tracked.